Detalhe da pesquisa
1.
Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
Breast Cancer Res
; 20(1): 19, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29566726
2.
Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.
Blood
; 124(20): 3101-9, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25170122
3.
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells.
Blood
; 119(1): 170-9, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22086413
4.
The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.
Blood
; 119(9): 2106-9, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234701
5.
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia.
Blood
; 119(7): 1726-36, 2012 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160382
6.
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy.
Blood
; 118(9): 2530-40, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768293
7.
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.
Proc Natl Acad Sci U S A
; 107(43): 18587-92, 2010 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937880
8.
The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.
Blood
; 115(1): 71-7, 2010 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19887677
9.
Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo.
Blood
; 115(21): 4198-205, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20237321
10.
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.
Blood Adv
; 6(18): 5494-5504, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640238
11.
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma.
Blood Adv
; 5(15): 2935-2944, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323957
12.
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.
Blood Adv
; 5(15): 2945-2957, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323958
13.
Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Clin Cancer Res
; 12(6): 1672-9, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16551848
14.
The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.
Haematologica
; 90(9): 1285-6, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16154859
15.
Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.
PLoS One
; 10(11): e0142379, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545243
16.
Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection.
Autoimmunity
; 37(1): 9-15, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15115306
17.
Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.
PLoS One
; 11(3): e0145040, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27007921
18.
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.
J Clin Invest
; 119(8): 2143-59, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620786
19.
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.
Blood
; 109(10): 4424-31, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255355
20.
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.
J Biol Chem
; 282(10): 7405-15, 2007 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-17197448